General Information of the Compound
| Compound ID |
CP0389916
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-[3-(1-methylbenzimidazol-2-yl)-1,2,4-oxadiazol-5-yl]-N-[(1-morpholin-4-ylcyclopentyl)methyl]piperidine-1-carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C26H35N7O3
|
||||||||||||||||||
| Molecular Weight |
493.612
|
||||||||||||||||||
| Canonical SMILES |
Cn1c(nc2ccccc12)-c1noc(n1)C1CCN(CC1)C(=O)NCC1(CCCC1)N1CCOCC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C26H35N7O3/c1-31-21-7-3-2-6-20(21)28-23(31)22-29-24(36-30-22)19-8-12-32(13-9-19)25(34)27-18-26(10-4-5-11-26)33-14-16-35-17-15-33/h2-3,6-7,19H,4-5,8-18H2,1H3,(H,27,34)
Show/Hide
|
||||||||||||||||||
| InChIKey |
GMMRMOPRQISHCY-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound